LifeCycle Pharma A/S - Report Pursuant to the Danish Securities Trading Act, Section 28(a)
09-03-09 kl. 9/3 2009 08:00 | Veloxis Pharmaceuticals 0,90 (+4,65%)
Se flere nyheder om Veloxis Pharmaceuticals
HORSHOLM, Denmark--(BUSINESS WIRE)--Mar. 9, 2009-- Pursuant to the Danish Securities Trading Act, Section 28(a), LifeCycle Pharma A/S (OMX: LCP) is required on a daily basis, to make public transactions in LifeCycle Pharma shares and related securities by persons discharging managerial responsibilities and persons / companies closely associated with these.
Name
Karin J. Hamberg
Reason for reporting
EVP & CMO
Issuer and ID code/ISIN
LifeCycle Pharma A/S / DK0060048148
Type of transaction Purchase of shares
Date of transaction
March 6, 2009
Relevant market
NASDAQ OMX Copenhagen
Number of traded securities
5,000
Market value
DKK 50,000 
English PDF
Skriv en kommentarer til denne artikel:
Send kommentar
| PRIS | 0,90 |
|---|---|
| ÆNDRING | +0,04 (+4,65%) |
| ÅBEN | 0,87 |
| SIDSTE LUK | 0,86 |
| DEBAT | - |
 |
